Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Lymph Node Biopsy After Neoadjuvant Oncological Treatment in Luminal B, HER-2 Positive and Triple Negative Breast Cancer Patients in Stage T1-3 N0-2 M0 at the Time of Diagnose

NCT03719833 is registered in ClinicalTrials.gov with Clinical Hospital Center Rijeka as lead sponsor.

NCT NCT03719833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03719833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Lymph Node Biopsy After Neoadjuvant Oncological Treatment in Luminal B, HER-2 Positive and Triple Negative Breast Cancer Patients in Stage T1-3 N0-2 M0 at the Time of Diagnose
Lead sponsor
Clinical Hospital Center Rijeka
Phase
Observational
Overall status
Completed
Start date
September 21, 2018
Completion date
July 28, 2025
Enrollment
230 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, neoadjuvant chemotherapy, sentinel lymph node biopsy